Long-term prognosis of patients with life-threatening ventricular arrhythmias induced by coronary artery spasm
Author(s) -
Moisés RodríguezMañero,
Teresa Olóriz,
JeanBenoît le Polain de Waroux,
Haran Burri,
Bahij Kreidieh,
Carlos de Asmundis,
Miguel Á. Arias,
Elena Arbelo,
Brais Díaz Fernández,
Juan FernándezArmenta,
Nuria Basterra,
María Izquierdo,
Ernesto Dı́az-Infante,
Gabriel Ballesteros,
Andrés Carrillo López,
Ignacio GarcíaBolao,
Juan BenezetMazuecos,
Victor Expósito-García,
Larraitz-Gaztañaga,
José Luis MartínezSande,
Javier GarcíaSeara,
José Ramón GonzálezJuanatey,
Rafaél Peinado
Publication year - 2017
Publication title -
ep europace
Language(s) - English
Resource type - Journals
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/eux052
Subject(s) - medicine , dihydropyridine , cardiology , retrospective cohort study , calcium channel blocker , coronary artery disease , calcium
Coronary artery spasm (CAS) is associated with ventricular arrhythmias (VA). Much controversy remains regarding the best therapeutic interventions for this specific patient subset. We aimed to evaluate the clinical outcomes of patients with a history of life-threatening VA due to CAS with various medical interventions, as well as the need for ICD placement in the setting of optimal medical therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom